Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-03-26, Stock:JNJ, The news for the past five days is as follows:
2021-03-19: NEWS1: What Scott Gottlieb Thinks About The Heated Exchange Between Anthony Fauci And Rand Paul.NEWS2: Biden’s vaccine goal was not a ‘moonshot challenge’: Analyst.NEWS3: Janssen's Ponvory Wins FDA Nod For Relapsing Multiple Sclerosis.NEWS4: UPDATE 2-U.S. FDA approves J&J's multiple sclerosis treatment; launch in April.NEWS5: Biden Administration Nears Goal of Administering 100 Million Vaccines.NEWS6: Could a Supply Glut Sink COVID Vaccine Stocks?.
2021-03-22: NEWS1: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS2: 'A fourth vaccine would absolutely be welcomed': Doctor on AstraZeneca vaccine.NEWS3: Publix expanding administration of J&J's COVID-19 vaccine to Tennessee, Georgia.NEWS4: The FDA has ‘a lot of positive things to look at’ with AstraZeneca vaccine: Doctor.NEWS5: UPDATE 1-White House promises more J&J COVID-19 shots after launch stalls.NEWS6: 'This is a low-cost people's vaccine:' Expert on India's Biological E vaccine.NEWS7: 2 Top Stocks for Retirees.NEWS8: UPDATE 1-Swiss approve Johnson & Johnson COVID-19 vaccine, haven't bought any.NEWS9: White House promises more J&J COVID-19 shots after launch stalls, declines to specify weekly shipment.NEWS10: UPDATE 1-Irish PM warns of 'trouble' in vaccine supply chain if EU blocks exports.NEWS11: Lifted COVID-19 restrictions ‘defies logic’ at this point in recovery: Doctor.NEWS12: AstraZeneca COVID-19 vaccine is 79% effective: U.S. study.NEWS13: Johnson & Johnson’s Janssen Receives FDA Approval For PONVORY Therapy; Street Sees Over 19% Upside.NEWS14: J&J's (JNJ) Multiple Sclerosis Drug Ponesimod Gets FDA Nod.NEWS15: Why I Didn't Jump on the Coronavirus Vaccine Stock Bandwagon.NEWS16: Should iShares Russell Top 200 Value ETF (IWX) Be on Your Investing Radar?.NEWS17: Airfinity CEO on Vaccination Campaign.
2021-03-23: NEWS1: Regenerative Medicine Attracted Record $20 Billion in Funding in 2020.NEWS2: UPDATE 3-J&J plant authorization clears way for big boost in U.S. COVID-19 shots.NEWS3: EU to extend vaccine export curbs to cover backloading, Britain: source.NEWS4: UPDATE 3-EU to extend vaccine export curbs to cover Britain, backloading -source.NEWS5: EU to tighten vaccine export rules in possible blow to firms backloading supplies - source.NEWS6: Biotech is ‘the superhero of the pandemic’: investor.NEWS7: Concerns raised over AstraZeneca vaccine trials: U.S officials.NEWS8: Biden team preps $3T economic package.NEWS9: Will the Fourth COVID-19 Vaccine in U.S. Get FDA Nod Soon?.
2021-03-24: NEWS1: Vaccine hesitancy can lead to development of ‘potent mutations’ in COVID-19: Doctor.NEWS2: U.S. must remain ‘worried about variants’: Doctor.NEWS3: Inflation expectations key to prevent spiraling inflation: Daco.NEWS4: Which COVID Vaccine Stock Is the Best Pick?.NEWS5: J&J COVID-19 Vaccine To Get Supply Boost As Manufacturing Partner Secures Key FDA Clearance.
2021-03-25: NEWS1: AstraZeneca (AZN) Reports New Efficacy Data on COVID-19 Vaccine.NEWS2: UPDATE 1-Thailand approves Johnson & Johnson's COVID-19 vaccine.NEWS3: Did You Participate In Any Of Johnson & Johnson's (NYSE:JNJ) Respectable 70% Return?.NEWS4: AstraZeneca Revises COVID-19 Vaccine Efficacy To 76% After Controversy.

Answer: Rise